Cardiovascular Systems Given New $50.00 Price Target at Dougherty & Co (CSII)
Dougherty & Co increased their target price on shares of Cardiovascular Systems (NASDAQ:CSII) from $28.00 to $50.00 in a research note issued on Wednesday, AmericanBankingNews.com reports. The firm currently has a “buy” rating on the stock. Dougherty & Co’s target price would suggest a potential upside of 86.92% from the company’s current price.
CSII has been the subject of a number of other recent research reports. Analysts at Benchmark Co. raised their price target on shares of Cardiovascular Systems to $35.00 in a research note to investors on Tuesday. Separately, analysts at Wunderlich raised their price target on shares of Cardiovascular Systems from $24.00 to $30.00 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Three investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $33.70.
In other Cardiovascular Systems news, VP Kevin J. Kenny sold 4,182 shares of the company’s stock on the open market in a transaction dated Wednesday, October 16th. The shares were sold at an average price of $22.95, for a total transaction of $95,976.90. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Cardiovascular Systems (NASDAQ:CSII) traded up 1.68% during mid-day trading on Wednesday, hitting $27.20. The stock had a trading volume of 137,305 shares. Cardiovascular Systems has a 52 week low of $10.12 and a 52 week high of $22.84. The stock’s 50-day moving average is $20.71 and its 200-day moving average is $19.78. The company’s market cap is $677.4 million.
Cardiovascular Systems (NASDAQ:CSII) last announced its earnings results on Wednesday, August 7th. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.30) by $0.02. The company had revenue of $28.80 million for the quarter, compared to the consensus estimate of $27.18 million. Analysts expect that Cardiovascular Systems will post $-1.14 EPS for the current fiscal year.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.